Literature DB >> 17076640

Particulate systems as adjuvants and carriers for peptide and protein antigens.

Ming Tao Liang1, Nigel M Davies, Joanne T Blanchfield, Istvan Toth.   

Abstract

The most common feature for antigen-delivery systems is their particulate nature. Together with a certain depot effect, it is the particulate nature that primarily dictates whether the antigen-delivery system will be successful in inducing a certain type and strength of immune response. In this article, we will summarize recent data on particulate delivery systems for peptide and protein antigens with a main focus on lipid or polymer-based particles, all of which possess high potential as both preventive and therapeutic vaccines for parenteral, nasal, and possibly oral administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076640     DOI: 10.2174/156720106778559029

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  16 in total

1.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

Review 2.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

3.  Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.

Authors:  Ashley L St John; Cheryl Y Chan; Herman F Staats; Kam W Leong; Soman N Abraham
Journal:  Nat Mater       Date:  2012-01-22       Impact factor: 43.841

4.  Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.

Authors:  Natalie A Parlane; Katrin Grage; Jason W Lee; Bryce M Buddle; Michel Denis; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

5.  Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.

Authors:  Douglas S Watson; Virginia M Platt; Limin Cao; Vincent J Venditto; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

6.  The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.

Authors:  Weili Yan; Leaf Huang
Journal:  Int J Pharm       Date:  2008-10-15       Impact factor: 5.875

7.  Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.

Authors:  Natalie A Parlane; D Neil Wedlock; Bryce M Buddle; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

8.  Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.

Authors:  Sok Bee Lim; Israel Rubinstein; Hayat Onyüksel
Journal:  Int J Pharm       Date:  2008-01-17       Impact factor: 5.875

9.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

Authors:  Maha Saad; Olga B Garbuzenko; Tamara Minko
Journal:  Nanomedicine (Lond)       Date:  2008-12       Impact factor: 5.307

10.  Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy.

Authors:  Wenxue Ma; Trevor Smith; Vladimir Bogin; Yu Zhang; Cengiz Ozkan; Mihri Ozkan; Melanie Hayden; Stephanie Schroter; Ewa Carrier; Davorka Messmer; Vipin Kumar; Boris Minev
Journal:  J Transl Med       Date:  2011-03-31       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.